1. Calpain is activated by .BETA.-adrenergic receptor stimulation under hypoxic myocardial cell injury
- Author
-
Hideaki Kawaguchi, Hisakazu Yasuda, and Kenji Iizuka
- Subjects
Programmed cell death ,medicine.medical_specialty ,Physiology ,Adrenergic beta-Antagonists ,chemistry.chemical_element ,Calcium ,Biology ,Protein degradation ,Calcium in biology ,Internal medicine ,Receptors, Adrenergic, beta ,medicine ,Animals ,Cells, Cultured ,Glycoproteins ,Chi-Square Distribution ,Calpain ,Myocardium ,Hypoxia (medical) ,Calcium Channel Blockers ,Cell Hypoxia ,Rats ,Enzyme Activation ,Endocrinology ,chemistry ,biology.protein ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Cyclase activity ,Intracellular - Abstract
This study was undertaken to investigate the correlation between hypoxic cell injury and protease activity, as well as the effects of alpha 1-, and beta-adrenergic blocking agents and calcium antagonists during hypoxia. Cell death during hypoxia rose to 80% after 6h. Calpain activity increased to 4 units during hypoxia, much higher than the 0.7 units seen in aerobic condition at 6h. This activity was markedly inhibited by calpain-specific inhibitor I (n-acetyl-leucyle-leucyle-norleucinal). alpha 1-adrenergic blocking agents did not affect calpain activity and cell death under hypoxia. On the other hand, beta-adrenergic blocking agents and calcium antagonists suppressed the calpain activity and decreased cell death during hypoxia. These beta-adrenergic blocking agents and calcium antagonists also inhibited intracellular calcium-influx during hypoxia. These results suggest the beta-adrenergic receptor stimulation activates adenylate cyclase activity and enhances calcium-influx during hypoxia. The elevated intracellular calcium concentration then stimulates calpain activity under hypoxia. These results prove that beta-adrenergic blocking agents and calcium antagonists prevent protein degradation during hypoxic cell injury.
- Published
- 1991